✦ LIBER ✦

LATE-TERM SAFETY AND EFFICACY OUTCOMES FOLLOWING TREATMENT WITH ZOTAROLIMUS-ELUTING STENTS: 5-YEAR RESULTS OF THE POOLED ENDEAVOR TRIALS PROGRAM

✍ Scribed by Kandzari, David E.; Leon, Martin B.; Wijns, William; Meredith, Ian T.; Fajadet, Jean; Cutlip, Donald E.; Mauri, Laura

Book ID: 122173334
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 72 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(10)61806-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-261: Long-Term Clinical Outcomes Fro

TCT-261: Long-Term Clinical Outcomes From the Zotarolimus-Eluting Stent Program: Final 5-Year Pooled Results From the ENDEAVOR Program

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 256 KB

TCT-404: Late Safety and Efficacy of a Z

TCT-404: Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

TCT-649 Safety and Efficacy of Overlappi

TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program

✍ Vasim Farooq; Roberto Diletti; Hector Garcia-Garcia; Laura Mauri; Jorge Belardi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Long-Term Clinical and Economic Analysis

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB